New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 22, 2013
07:52 EDTSNYEMA gives positive recommendations for Sanofi's Hexacima, Hexyon
The Committee for Medicinal Products for Human Use adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Hexacima, 0.5 ml, suspension for injection intended for primary and booster vaccination of infants and toddlers from six weeks to 24 months of age against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and invasive diseases caused by Haemophilus influenzae type b. The Committee also adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Hexyon, 0.5 ml, suspension for injection intended for primary and booster vaccination of infants and toddlers from six weeks to 24 months of age against the same diseases. The applicant for these medicinal products is Sanofi Pasteur.
News For SNY From The Last 14 Days
Check below for free stories on SNY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
May 23, 2013
08:18 EDTSNYMerrimack completes enrollement in a Phase 2 study of MM-121 with Sanofi
Subscribe for More Information
May 21, 2013
07:44 EDTSNYSachs Associates to host a forum
Subscribe for More Information
May 20, 2013
17:26 EDTSNYRegeneron, Genentech, Sanofi enter into 'Zaltrap agreement'
Subscribe for More Information
11:27 EDTSNYAppeals court reverses, remands patent ruling in Sanofi suit against Mylan, Teva
Subscribe for More Information
May 17, 2013
08:03 EDTSNYSanofi reports positive topline results from pivotal Phase III Jakarta study
Subscribe for More Information
05:18 EDTSNYSanofi says JAK2 inhibitor for myelofibrosis met primary endpoint
Subscribe for More Information
May 15, 2013
15:16 EDTSNYSanofi systemic sclerosis treatment designated for orphan drug status
Subscribe for More Information
05:39 EDTSNYSanofi, Regeneron announce patient enrollment in two Phase 3 trials
Subscribe for More Information
May 13, 2013
09:44 EDTSNYSeveral companies reportedly interested in buying Adcock Ingram, Globes says
Subscribe for More Information
07:30 EDTSNYTechConnect to host a summit
2013 National Innovation Summit is being held in Washington, D.C. on May 12-16.

Sign up for a free trial to see the rest of the stories you've been missing.